2024/07/17 19:30:15 | |
---|---|
Price | |
71.00 EUR | |
Difference | -1.39% (-1.00) |
ISIN | NL0011832936 |
Symbol | COPN |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 1,153 EUR |
Benchmark | MSCI WORLD INDEX (STRD, UHD) |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 72.00 EUR |
High | 72.00 EUR |
Low | 70.50 EUR |
Close (prev. day) | 72.00 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 6 |
Last size | 0 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2024/07/12 |
![]() |
Global Equity Ratings |
![]() |
2024/06/21 |
![]() |
Global Equity Ratings |
![]() |
2024/06/14 |
![]() |
Global Equity Ratings |
![]() |
2024/05/29 |
![]() |
Global Equity Ratings |
![]() |
2024/04/26 |
![]() |
Global Equity Ratings |
![]() |
2024/07/17 19:30:15 | |
---|---|
Price | |
71.00 EUR | |
Difference | -1.39% (-1.00) |
ISIN | NL0011832936 |
Symbol | COPN |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 1,153 EUR |
Benchmark | MSCI WORLD INDEX (STRD, UHD) |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 72.00 EUR |
High | 72.00 EUR |
Low | 70.50 EUR |
Close (prev. day) | 72.00 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 6 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | - | - | - |
Perf (abs.) | - | - | - |
Beta | 0.35 | 0.62 | 0.65 |
Volatility | - | - | - |
Ø price 5 days | Ø volume 5 days (pcs.) | 71.60 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 72.92 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | - EUR (-) |
Ø price 250 days | Ø volume 250 days (pcs.) | - EUR (-) |
YTD High | date | - EUR (-) |
YTD Low | date | - EUR (-) |
52 Weeks High | date | - EUR (-) |
52 Weeks Low | date | - EUR (-) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/07/17 | 17:35 | 72.00 EUR | 0.01 | 2 |
Tradegate | 2024/07/17 | 22:02 | 72.00 EUR | 0.00 | 1 |
Stuttgart | 2024/07/17 | 15:44 | 71.00 EUR | 0.00 | 7 |
SIX Swiss Exchange | 2024/07/17 | 17:30 | 69.90 CHF | 0.60 | 177 |
Munich | 2024/07/17 | 08:18 | 72.50 EUR | 0.00 | 2 |
London Stock Exchange | 2024/07/15 | 16:59 | 71.00 CHF | 0.32 | 1 |
Frankfurt | 2024/07/17 | 17:20 | 70.50 EUR | 0.00 | 7 |
FINRA other OTC Issues | 2024/06/21 | 15:30 | 80.25 USD | 0.00 | 1 |
Duesseldorf | 2024/07/17 | 19:30 | 71.00 EUR | 0.00 | 6 |
COSMO PHARMACEUTICALS NV |
- - |
Riverside II, Sir John Rogerson's Quay - 2 Dublin |
Telefon: +353-1-8170370 |
Fax: +353-1-8230718 |
E-mail: - |
Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland. |
Alessandro Della Cha | Chairman of Managing Board |
Biagio Viganò | Member of Executive Committee |
Luigi Longo | Member of Executive Committee |
Marco Lecchi | Member of Executive Committee |
Niall Donnelly | Member of Executive Committee |
Roberto Villa | Member of Executive Committee |
Alessandro Chà | Chairman of Supervisory Board |
John OšDea | Member of Supervisory Board |
Maria Grazia Roncarolo | Member of Supervisory Board |
Mauro Ajani | Member of Supervisory Board |
Niall Donnelly | Member of Supervisory Board |
Silvana Perretta | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer